Identification | Back Directory | [Name]
D-AMPHETAMINE HYDROCHLORIDE | [CAS]
51-64-9 | [Synonyms]
C07884 Dexacaps Dexedrine dexidrine NSC-73713 Dexamfetamine D-AMPHETAMINE amphetamine(d) Dexamphetamine (S)-AMPHETAMINE S(+)-AMPHETAMINE Amphetamine, (d) DELTA-AMPHETAMINE D-(S)-amphetamine DEXTRO-AMPHETAMINE component of Amodex component of Biphetamine D-1-Phenyl-2-aminopropan d-a-Methylphenethylamine D-1-Phenyl-2-aminopropane D-2-Amino-1-phenylpropane (S)-1-phenylpropan-2-amine (-)-alpha-Phenylpropylamine D-AMPHETAMINE HYDROCHLORIDE S(+)-Amphetamine, 1.0 mg/mL KWTSXDURSIMDCE-QMMMGPOBSA-N D-alpha-methylphenethylamine D-Amphetamine Solution, 100ppm +/- AMPHETAMINE (5 AMPS/PKGE) (aS)-a-Methyl-benzeneethanamine Phenethylamine, D-alpha-methyl- (S)-(+)-beta-Phenylisopropylamine alpha-methylphenethylamine,d-form Phenethylamine, alpha-methyl-, d- alpha-Methylphenethylamine, d-form Benzeneethanamine, α-methyl-, (αS)- D-AMPHETAMINE HYDROCHLORIDE USP/EP/BP S(+)-Amphetamine (dextro-Amphetamine) Benzeneethanamine, alpha-methyl-, (S)- S(+)-Amphetamine (dextro-Amphetamine) solution | [EINECS(EC#)]
200-112-1 | [Molecular Formula]
C9H14ClN | [MDL Number]
MFCD01708025 | [MOL File]
51-64-9.mol | [Molecular Weight]
171.67 |
Hazard Information | Back Directory | [Uses]
CNS stimulant; anorexic. More active isomer of Amphetamine. Induces release of catecholamines and serotonin by displacing the monoamines from their vesicular storage sites; blocks catecholamine reuptake.
Controlled substance (stimulant) | [Definition]
ChEBI: A 1-phenylpropan-2-amine that has S configuration. | [Brand name]
Dexampex (Teva); Dexedrine (GlaxoSmithKline); Dextrostat (Shire); Ferndex (Ferndale). | [World Health Organization (WHO)]
Schedule II of the 1971 Convention on Psychotropic Substances. See WHO
comment for amfetamine.
(Reference: (UNCPS2) United Nations Convention on Psychotropic Substances (II),
, , 1971) | [Synthesis]
The compound can be prepared by optical
resolution of amphetamineor directly
from (-)-norephedrine by conversion to
the (+)-chloroamine followed by catalytic hydrogenation .
![Synthesis_51-64-9](/NewsImg/2024-03-19/6527398832631149786830761.png) |
Safety Data | Back Directory | [Hazard Codes ]
F,T | [Risk Statements ]
11-23/24/25-39/23/24/25 | [Safety Statements ]
16-36/37-45 | [RIDADR ]
3249 | [WGK Germany ]
1 | [HazardClass ]
6.1(a) | [PackingGroup ]
II | [Safety Profile]
Poison by ingestion,
subcutaneous, intravenous, and
intraperitoneal routes. Experimental
reproductive effects. Chronic exposure
causes central nervous system damage and
blood-pressure effects. When heated to
decomposition it emits toxic NOx. See other
amphetamine entries. | [Hazardous Substances Data]
51-64-9(Hazardous Substances Data) | [Toxicity]
LD50 orl-rat: 38 mg/kg TXAPA9 18,185,71 |
|